~~<i id='7ABA38E2F1'><strike id='7ABA38E2F1'><tt id='7ABA38E2F1'><pre id='7ABA38E2F1'></pre></tt></strike></i>~~

Home» explore» comprehensive

comprehensive

author：explore 2025-10-02 14:03:28 Page View：29559

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Diabetes: Better shows data on app’s benefit with GLP-1s

Better Therapeutics announced top-line data suggesting that its prescription app for diabetes treatment, AspyreRx, can boost the impact of GLP-1 diabetes treatments. According to the release, a subgroup analysis of 160 participants in its pivotal trial on GLP-1 treatment found that the behavior modification app produced statistically significant reductions in A1C compared to a control group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Key House panel plots a new health care package
Next article： How to save PrEP access — and even expand it

leisure time

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

STAT Virtual Event: The State of Biosimilars: What to Watch

Editor’snote:Arecordingoftheeventisembeddedbelow.NowthatbiosimilarversionsofHumiraarestartingtoarriv

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

Dario to buy mental health app maker Twill in cash and stock deal

AdobeDarioHealth,whichmakesappsformanagingchronicdiseases,todayannounceditwillacquiredigitalmentalhe